PERSPECTA

News from every angle

← Back to headlines

Novavax sets 2026 revenue and 2028 opex targets

Novavax is targeting $230M-$270M in adjusted revenue for 2026 and refining its 2028 operational expenses to $150M-$200M.

6 May, 18:23 — 6 May, 18:23
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed2h ago

Novavax targets $230M-$270M 2026 adjusted revenue while refining 2028 opex to $150M-$200M

Read full article →

Related Stories

Anambra State Selected as Pilot for Nigeria's HIV Prevention Plan

just now

Greek Student Collapses During School Trip in Eretria

12m ago

Hantavirus Outbreak on Cruise Ship Leads to Evacuations, Ship Heads to Spain

15m ago

Hantavirus Outbreak on Cruise Ship Prompts Evacuations

15m ago